I agree that this site is using cookies. You can find further informations here.
X
Sriraman, Shravan Kumar
28  results:
Search for persons X
?
1

Development of an 18F-labeled anti-human CD8 VHH for same-d..:

Sriraman, Shravan Kumar ; Davies, Christopher W. ; Gill, Herman...
European Journal of Nuclear Medicine and Molecular Imaging.  50 (2022)  3 - p. 679-691 , 2022
Link: https://doi.org/10.1007/..
 
?
2

Anti-cancer activity of doxorubicin-loaded liposomes co-mod..:

Sriraman, Shravan Kumar ; Salzano, Giusseppina ; Sarisozen, Can.
European Journal of Pharmaceutics and Biopharmaceutics.  105 (2016)  - p. 40-49 , 2016
Link: https://doi.org/10.1016/..
 
?
3

Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-L..:

Sriraman, Shravan Kumar ; Pan, Jiayi ; Sarisozen, Can..
Molecular Pharmaceutics.  13 (2016)  2 - p. 428-437 , 2016
Link: https://doi.org/10.1021/..
 
?
4

Reversal of Chemoresistance in Ovarian Cancer by Co‐Deliver..:

Sriraman, Shravan Kumar ; Zhang, Yilin ; Lengyel, Ernst.
The FASEB Journal.  29 (2015)  S1 - p. , 2015
Link: https://doi.org/10.1096/..
 
?
5

Cytotoxicity of PEGylated liposomes co-loaded with novel pr..:

Sriraman, Shravan Kumar ; Geraldo, Vananelia ; Luther, Ed..
Journal of Controlled Release.  220 (2015)  - p. 160-168 , 2015
Link: https://doi.org/10.1016/..
 
?
6

Enhanced in vitro cancer cell cytotoxicity of dual ligand‐t..:

Sriraman, Shravan Kumar ; Torchilin, Vladimir
The FASEB Journal.  28 (2014)  S1 - p. , 2014
Link: https://doi.org/10.1096/..
 
?
7

Polyethyleneimine-lipid conjugate-based pH-sensitive micell..:

Sawant, Rupa R. ; Sriraman, Shravan Kumar ; Navarro, Gemma...
Biomaterials.  33 (2012)  15 - p. 3942-3951 , 2012
Link: https://doi.org/10.1016/..
 
?
8

Anti-Cancer Activity of Doxorubicin-Loaded Liposomes Co-Mod..:

Sriraman, Shravan Kumar ; Salzano, Giusseppina ; Sarisozen, Can.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931959/.  , 2016
Link: http://www.ncbi.nlm.nih...
 
?
9

Reversal of chemoresistance in ovarian cancer by co-deliver..:

Zhang, Yilin ; Sriraman, Shravan Kumar ; Kenny, Hilary A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050109/.  , 2016
Link: http://www.ncbi.nlm.nih...
 
?
10

Cytotoxicity of PEGylated Liposomes Co-Loaded with Novel Pr..:

Sriraman, Shravan Kumar ; Geraldo, Vananelia ; Luther, Ed..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4688222/.  , 2015
Link: http://www.ncbi.nlm.nih...
 
?
11

The evaluation of enzyme-mediated forms of [18F]AlF-RESCA-V..:

Gill, Herman ; Sriraman, Shravan ; Ogasawara, Annie...
Nuclear Medicine and Biology.  126-127 (2023)  - p. 108706 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Preclinical development of ZED8, an 89Zr immuno-PET reagent..:

Ogasawara, Annie ; Kiefer, James R. ; Gill, Herman...
European Journal of Nuclear Medicine and Molecular Imaging.  50 (2022)  2 - p. 287-301 , 2022
Link: https://doi.org/10.1007/..
 
?
13

Correction to: Preclinical development of ZED8, an 89Zr imm..:

Ogasawara, Annie ; Kiefer, James R. ; Gill, Herman...
European Journal of Nuclear Medicine and Molecular Imaging.  50 (2022)  2 - p. 631-631 , 2022
Link: https://doi.org/10.1007/..
 
?
14

Factors Influencing Social and Community Participation of P..:

Babu, Heavenna ; Sriraman, Sheetal ; Karthikbabu, Suruliraj..
Indian Journal of Community Medicine.  49 (2024)  1 - p. 52-55 , 2024
Link: https://doi.org/10.4103/..
 
?
15

Health Care Equity Through Intelligent Edge Computing and A..:

Lakshminarayanan, Vishal ; Ravikumar, Aswathy ; Sriraman, Harini..
Journal of Multidisciplinary Healthcare.  16 (2023)  - p. 2839-2859 , 2023
Link: https://doi.org/10.2147/..
 
1-15